password
username
Sponsored by CakeMail, an email marketing software.
Newsletter preview


 


March 31, 2008

Table of Contents

LATEST SUMMARIES

CIVIL PROCEDURE, INTELLECTUAL PROPERTY, INTERNATIONAL LAW, PATENT, PROBATE, TRUSTS & ESTATES
• Akira Akazawa v. Link New Tech. Int'l, Inc.

DRUGS & BIOTECH, INTELLECTUAL PROPERTY, PATENT
• Ortho-McNeil Pharm., Inc. v. Mylan Labs., Inc.

You May FREELY Redistribute This E-Mail in Whole
To view the full-text of cases you must sign in to FindLaw.com.

LATEST SUMMARIES

CIVIL PROCEDURE, INTELLECTUAL PROPERTY, INTERNATIONAL LAW, PATENT, PROBATE, TRUSTS & ESTATES
Akira Akazawa v. Link New Tech. Int'l, Inc., No. 2007-1184
In a patent dispute, summary judgment for defendant based on lack of standing is vacated where issues of Japanese intestacy law must be resolved by the district court in order to determine whether plaintiff owned the patent at issue, and therefore possessed standing to bring the present suit. Read more...

DRUGS & BIOTECH, INTELLECTUAL PROPERTY, PATENT
Ortho-McNeil Pharm., Inc. v. Mylan Labs., Inc. , No. 2007-1223
A judgment permanently enjoining defendant from infringing a patent claiming the anticonvulsive drug topiramate and resetting the approval date for defendant's Abbreviated New Drug Application (ANDA) is affirmed where the district court: 1) correctly ruled on claim construction, inequitable conduct, obviousness, and enablement; and 2) it did not err in resetting the effective date of the ANDA under 35 U.S.C. section 271(e)(4)(A). Read more...


 You are currently subscribed to fed-caselaw as: kallyorama@gmail.com .
To manage your newsletter accounts go to: http://newsletters.findlaw.com/nl/sub/review-account.jsp
or to ***, send a blank email to leave-3377096-1395333.ec4e5fe2ff8da97a5c0d69a0dac019e5@info.legalminds.org